All In Biotech

Drug Trial Radar · NCT07371728

Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery

Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery: A Pilot Randomized-Controlled Trial

Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Oct 15, 2026

Primary completion

Jun 1, 2027

Study completion Jun 1, 2028

Sponsor

Lead sponsor
Sir Mortimer B. Davis - Jewish General HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 28, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This project is being carried out to study the use of a medication to reduce nausea and vomiting after ear surgery.

Conditions

  • Otologic Disease

Interventions

  • AprepitantDrug

    Participants will be randomly assigned to the intervention or control group in a 1:1 ratio. Oral aprepitant of 80mg will be administered within an hour of induction for an otological surgery.

  • PlaceboOther

    Participants will be randomly assigned to the intervention or control group in a 1:1 ratio. An oral placebo capsule will be administered within an hour of induction for an otological surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of clinically important postoperative nausea and vomitingTime frame: 6h to 48h postoperatively

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Jewish General Hospital

    Montreal, Quebec, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.